Cyklokapron is approved by the Food and Drug Administration (FDA) for short-term use in people with hemophilia. Cyklokapron may be used for two to eight days to reduce or prevent hemorrhage during and after dental surgery. Cyklokapron is also known by its drug name, Tranexamic acid.
Cyklokapron is an antifibrinolytic. It is believed that Cyklokapron works in cases of hemophilia by preventing the breakdown of blood clots.
How do I take it?
Prescribing information states that Cyklokapron is taken as an intravenous injection.
Cyklokapron comes as a solution in vials and ampules.
The FDA-approved label for Cyklokapron lists common side effects including nausea, vomiting, diarrhea, giddiness, low blood pressure, and rash.
Rare but serious side effects listed for Cyklokapron include hypersensitivity reactions.
For more details about this treatment, visit:
Cyklokapron prescribing information (PDF) – Pfizer
Treatment of Hemophilia – Hemophilia Federation of America